Garden City Dermatology, Garden City, New York, USA.
Dermatol Online J. 2024 Jun 15;30(3). doi: 10.5070/D330363868.
A unique dermatopathology incident arose after administration of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine. Specifically, a transient purpuric interface dermatitis occurred 5 days post-second vaccine with the presentation of erythematous papules with erythema multiforme-type findings. A patient developed purpuric interface dermatitis with micro-vesiculation post-vaccination which ultimately resolved without sequelae.
在接种 mRNA-1273 SARS-CoV-2(Moderna)疫苗后出现了一种独特的皮肤科病理事件。具体来说,第二次接种疫苗后 5 天出现短暂的紫癜性界面性皮炎,表现为红斑多形性的红斑丘疹。一名患者在接种疫苗后出现紫癜性界面性皮炎和微疱疹,最终无后遗症消退。